2016
DOI: 10.1515/cclm-2016-0329
|View full text |Cite
|
Sign up to set email alerts
|

Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome

Abstract: Low adropin level in circulation is related to ED and has a close association with FMD. Any alterations in its level may be of help in order to assess the development of ED before the occurrence of clinical symptoms in patients with metabolic syndrome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 28 publications
0
24
0
Order By: Relevance
“…This result suggests that the change in the serum adropin concentration may be one mechanism by which the exercise intervention improved vascular endothelial function in obese adolescents. Previous studies also demonstrated that a lower serum adropin level was associated with endothelial dysfunction using flow-mediated dilatation in patients with type-2 diabetes mellitus and metabolic syndrome 36 , 37 . Aerobic exercise training increased the serum adropin level and improved arterial stiffness and adiposity in obese adults 38 .…”
Section: Discussionmentioning
confidence: 83%
“…This result suggests that the change in the serum adropin concentration may be one mechanism by which the exercise intervention improved vascular endothelial function in obese adolescents. Previous studies also demonstrated that a lower serum adropin level was associated with endothelial dysfunction using flow-mediated dilatation in patients with type-2 diabetes mellitus and metabolic syndrome 36 , 37 . Aerobic exercise training increased the serum adropin level and improved arterial stiffness and adiposity in obese adults 38 .…”
Section: Discussionmentioning
confidence: 83%
“…It has also been shown that adropin can regulate the expression of hepatic lipid synthesis genes [8]. In addition, a large number of population studies confirmed that the serum levels of adropin were negatively correlated with the risk factors of metabolic diseases [14], [15], [16]. However, adropin's role in regulating nonalcoholic steatohepatitis was still unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Low serum adropin levels are associated with reduced NO bioavailability in the endothelium, which is associated with the endothelial dysfunction (ED) that is predictor of atherosclerosis 30 . In a study of 110 patients with MetS, reduced serum adropin levels were associated with ED and with flow‐mediated dilatation (FMD) 31 …”
Section: Adropin Regulates Biological Pathways That Are Directly or Imentioning
confidence: 99%